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A B S T R A C T
Purpose of this study was to compare the effects of combined therapy using nonsteroid anti-inflammatory analgetics
and corticosteroids, and the effects of the mono-therapy with same drugs for post-operative pain after surgical removal of
the impacted mandibular third molar. The study was completed at the Department of Oral Surgery and at the Department
of Dental Medicine of the Public Institute Health Center Zenica in Zenica. The research included 60 patients divided into
3 groups using random selection, including both sexes. Age range was between 18 and 45 years. All participants came
without any pain or other inflammatory symptoms at the time of oral surgical intervention. Two medicaments were pre-
scribed after the impacted tooth removal: 15 mg of nonsteroid anti-inflammatory analgesic drug (Meloxicam, Bosna-
lijek, BiH) and 32 mg Methylprednisolone (corticosteroid, Bosnalijek, BiH). Both medicaments were applied per os, ac-
cording to schedule determined by the research protocol. The level of post-surgical pain was evaluated by the 1–10 visual
analog scale (VAS). One way ANOVA was made with Tuckey post-hoc tests. Statistically significant difference (p<0.05)
was found between the group treated with mono therapy and the group treated with combined therapy. Application of
mono therapy using only corticosteroids or only nonsteroid anti-inflammatory pain-killers was less effective compared to
the combined therapy with both medicaments after surgical removal of the impacted mandibular third molar.
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Introduction
The post-surgical complications may occur after each
surgical removal of the impacted mandibular third mo-
lar. Mayor complications may rarely appear in a form of
paresthesia or fracture of the mandible, but minor com-
plications such as swelling, pain and trismus are more or
less predictable. The increase in incidence of the post-
surgical complications may be correlated with the dura-
tion of surgical treatment, age of the patient, as well as
with the depth of the impacted mandibular third molar.
During the first 4 to 7 days after the surgical treatment,
the negative impact to the quality of life can be expected.
After that, it is common to observe the decrease of the ex-
pected post-surgical complications resulting in a signifi-
cant improvement of the quality of life1–11.
Removal of the impacted mandibular third molar is a
widely used model for evaluation of the medicaments, as
almost always minor post-surgical complications may be
expected1,2. Thus, the patients are not exposed to experi-
mental infliction in order to provoke the post-surgery
complications, which is a significant ethical aspect in the
research.
The aim of the study was to compare the effects of the
monotherapy using nonsteroid anti-inflammatory anal-
getic drugs or corticosteroids, and the effects of the com-
bined therapy with anti-inflammatory analgetic drugs
and corticosteroids on the post-surgical pain relieve after
the removal of the impacted mandibular third molar.
Material and Methods
The research included 60 patients who had surgical
removal of the impacted third molar. All the molars fin-
ished their growth and the roots were developed, and the
molars had mesioangular position (Winter II Class). All
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surgical procedures were completed at the Department
of Oral Surgery, Department of Dental Medicine of the
Public Institute Health Center Zenica in Zenica, BiH.
Surgical approach was (cut according to Sicher) made
with standard surgical instruments and uniform corti-
cotomy from the vestibular side in each patient. Patients
were divided into three groups using the random selec-
tion. Each group included twenty patients, both genders,
with age range from 18 to 45 years. Diagnose of the im-
pacted third mandibular molar was made after the clini-
cal examination and RTG analysis (panoramic radio-
graph). The patients who had unfavorable kidney or liver
conditions, blood dyscrasia, gastric ulceration, unfavor-
able heart conditions, and any allergic reactions reported
in the past to some of the medicaments prescribed in the
present study were excluded, as well as patients in preg-
nancy and lactation. The research did not include the pa-
tients who had been taking analgesics or anti-inflamma-
tory medicaments 24 hours prior to the surgery, nor the
patients with recognizable pre-surgery swelling, post-
surgery bleeding or infection.
All patients gave the written consent, which had been
obtained prior the treatment.
Impacted teeth were extracted under the local anes-
thesia with the dosage of 4 ccm of the 2% Xylocain with
adrenalin (1:80000).
A file was made for every patient with his RTG re-
cords and the results obtained in the study. Detailed de-
scription of the wound, condition of the suture and the
healing status during the post-surgery period were re-
corded.
The level of pain was evaluated twice: pain 2 (level of
pain on the second day after the surgical treatment) and
pain 7 (level of pain on the seventh day after the surgical
treatment), both based on the patient’s self-evaluation
using the analogue-visual scale from 1 to 10 (VAS).
Two medicaments were used, Meloxicam (Melox Forte)
15 mg (nonsteroidal anti-inflammatory analgesic drug
from the group of selective inhibitors of cyklooxsygena-
se-2) and Methylprednisolone (Medrol) 32 mg (syntheti-
cally manufactured glucocorticoid). Both medicaments
were applied per os according to following scheme: the
first group received only the Meloxicam therapy of 15
mg, one hour before the surgical procedure and 15 mg
daily for the next two days. The second group of subjects
received only Methylprednisolone therapy of 32 mg, one
hour before the surgical procedure and 32 mg twelve
hours after the surgical procedure. The third group of
subjects received the combined therapy of the both medi-
caments (Meloxicam + Methylprednisolone).
The software SPSS 16. for Windows was used (Chi-
cago, Illinoiss, USA). The normality of the distribution
was tested by the Kolmogorov-Smirnov test. The descrip-
tive statistics was calculated. The significance of the dif-
ferences between the mean values was assessed by the
one-way ANOVA and Tuckey post-hoc tests.
Results
Mean values of the self-assessment of the pain level
(1–10 visual-analogue scale points) after post-surgical
therapy using different drugs are presented in the Fig-
ure 1.
Table 1 presents Tukey HSD tests (the statistical sig-
nificance of the differences in pain level between the 3
groups under different post-surgical drug therapy). There
was a statistically significant difference (p<0.05) be-
tween the groups with monotherapy with Medrol or
monotherapy with Melox Forte (in the both observed
time intervals: the second and the seventh day after the
surgical treatment), and the combined Medrol and Melox
Forte therapy. The combined therapy had significantly
lower pain level, as assessed using the 1–10 VAS.
Discussion
Oral surgical procedure causes »damage« to tissue
which leads to release of potassium, serotonins and hista-
mines from the damaged cells, and the release of brady-
kinin from the damaged blood vessels. This causes the
activation of nocioceptors, change of the tissue coloration
and edema as a response of the tissue. Bradykinin causes
release of prostaglandin and activation of nocioceptors.
Prostaglandins induce the increase of permeability of blood
vessels and increase of sensitivity of nocioceptors. Trans-
fer of neural impulses from the irritated nerve fibers in-
duces the release of the P substance in and around the
tissue damage, which is responsible for further release of
Bradykinin and histamine which activate other nocio-
ceptors and worsen the reaction of the tissue to injury.
Basis for clinic experiments of evaluation of different
medicaments after surgical procedures is a surgically in-
duced inflammatory process manifested with classical
E. Selimovi} et al.: Pain Relieve after Extraction of Impacted Wisdom Teeth, Coll. Antropol. 35 (2011) 1: 133–136
134
Fig. 1. Pain level on the second and the seventh day after the surgi-
cal treatment for the three groups of patients (the first group used
only nonsteroidal anti-inflammatory analgesic drug (Melox Forte),
the second group used corticosteroid (Medrol) and the third group
used the combined therapy with the both medicaments.
symptoms like pain, swelling, heat and various func-
tional damages.
Pre-medication with Meloxicam has shown as an ef-
fective way to influence the post-surgery pain3. The de-
scription of pain is always subjective4. International as-
sociation for pain defines it as »unpleasant feeling and
emotional experience which is related to real or potential
damage of tissue, or it is described with expression de-
scribing such similar damage«5. Different scales and que-
stionnaires have been reported in different studies for
self-assessment of the level of pain, or satisfaction with
the therapy or for assessment of the oral-related quality
of life12–21. Visual-analogue scale from 1 to 10 was used in
this study for assessment of the level of post-operative
pain, as it was more comprehensible to the patients than
just visual scale. Moreover, the similar grading system is
being used in schools and faculties in Bosnia.
Systemic approach to solving problem of post-surgery
pain after oral surgical procedures most commonly result-
ed in application of analgesic drugs and rarely cortico-
steroids. Clinical practice includes a widespread applica-
tion of analgo-antipyretics, most commonly nonsteroidal
anti-inflammatory antirheumatic drugs, which ensure
effective analgesis in moderate post-surgical pain. Some-
times the anti-inflammatory analgesic drugs were ap-
plied with opioid group of analgesic drugs, prescribed in
strong post-surgical pain7.
However, application of any medicament includes side
effects which may be developed, and the therapy is di-
rected towards finding the medicaments with best thera-
peutic effect and the least side effects.
All opiates cause the depression of the center for
breathing, sedation, sleepiness, sluggishness, nausea, vo-
miting and constipation. One side effect is also the mood
change which varies from euphoria to dysphoria. Thus,
inclusion of opiates into the post-surgical medicamentous
therapy can be taken into account only in case of failure
of the maximum dose of nonsteroidal anti-inflammatory
analgesics, and only mild opiates may be prescribed.
The Meloxicam has analgesic and anti-inflammatory
effect and it has been proven successful in the control of
the post-surgery pain after the removal of the impacted
mandibular third molars. Calvo et al. examined the effec-
tiveness of the Meloxicam in 15 and 7.5 mg doses and
found significantly better results using higher Meloxi-
cam dose8. They determined that the higher dose of
Meloxicam should be recommended when the oral surgi-
cal procedure includes osteotomy.
Buyukkurt et al. examined the effect of the individual
intramuscular doses of Prednisolone and the combina-
tion of Prednisolone-Diclofenac therapy on the post-sur-
gery pain, trismus and edema after the surgical removal
of the impacted mandibular third molar9. Their study
proved that the combination of Prednisolon-Diclofenac
was better fot the pain suppression in comparison with
the control group (p<0.05). Schultze-Mosgau et al. test-
ed the combined therapy with nonsteroidal analgesic
Ibuprofen and corticosteroid Methylprednisolone for swell-
ing and pain10. The Efficiency of 32 mg of corticosteroid
Methylprednisolone for swelling and pain administered
12 hours before and after surgical treatment in combina-
tion with 400 mg of nonsteroidal anti-inflammatory an-
algesic Ibuprofen a day after the surgery and two follow-
ing days after the removal of the impacted mandibular
third molar was tested in that research. Authors con-
cluded that the combined therapy with Ibuprofen and
Methylprednisolone caused good analgesia and anti-in-
flammatory activity. Bamgbose et al. compared the mu-
tual effect of the corticosteroid Dexametazon and the
nonsteroidal anti-inflammatory analgesic Diclofenac K
with the individual effect of the nonsteroidal anti-inflam-
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TABLE 1
COMPARISON OF GROUPS USING TUKEY HSD TEST CONSIDERING THE PAIN PARAMETERS FOR THE SECOND
AND SEVENTH DAY AFTER THE SURGERY
Pain
parameters (I) Therapy (J) Therapy
Average value
of the difference Standard error 95% trust interval
Pain_B2 Medrol Melox forte .800(*) .094 .57 1.03
Combined 1.900(*) .094 1.67 2.13
Melox forte Medrol –.800(*) .094 –1.03 –.57
Combined 1.100(*) .094 .87 1.33
Combined Medrol –1.900(*) .094 –2.13 –1.67
Melox forte –1.100(*) .094 –1.33 –.87
Pain_B7 Medrol Melox forte 1.050(*) .152 .68 1.42
Combined 1.750(*) .152 1.38 2.12
Melox forte Medrol –1.050(*) .152 –1.42 –.68
Combined .700(*) .152 .33 1.07
Combined Medrol –1.750(*) .152 –2.12 –1.38
Melox forte –.700(*) .152 –1.07 –.33
* Values of the difference with level of significance 0.05
matory analgesic Diclofenac K11. The combined therapy
with corticosteroids and nonsteroidal anti-inflammatory
analgesics had a stronger impact on the decrease of pain
and post-surgery swelling even after 48 hours (p<0.05)
compared to individual nonsteroidal anti-inflammatory
analgesic.
The results of the present study are in line the above
mentioned studies. The pain supression (releif) after the
impacted third mandibular molar removal the combined
therapy with nonsteroidal anti-inflammatory analgesic
drugs and corticosteroids (Medrol and Melox Forte) is su-
perior to monotherapy with each of the mentioned drugs.
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SMANJENJE BOLA NAKON VA\ENJA IMPAKTIRANOG DONJEG UMNJAKA OVISNO O VRSTI
MEDIKAMENTOZNE TERAPIJE
S A @ E T A K
Svrha rada je uporediti utjecaj kombinirane terapije nesteroidnim antiinflamatornim analgeticima i kortikosteroidi-
ma i monoterapije istim lijekovima na otklanjanje post-operativnog bola nakon kirur{kog zahvata: va|enja impaktira-
nog donjehg umnjaka. Rad je napravljen u Zavodu za Oralnu kirurgiju, Odjela za Stomatologiju, Instituta za zdravlje
Zenica u Zenici, BiH. Uklju~eno je 60 pacijenata oba spola podijeljenih u 3 grupe. Dobni raspon bio je od 18 do 45 godina.
Nitko od ispitanika nije imao/la bolne ili upalne senzacije neposredno prije kirur{kog zahvata. Dva lijeka prepisana su
nakon zahvata: 15 mg nesteroidnog anti-inflamatornog analgetika (Meloxicam, Bosnalijek, BiH) i 32 mg Methylpredni-
solone (kortikosteroid, Bosnalijek, BiH). Oba lijeka uzeta su per os prema shemi protokola. Razina post-kirur{ke boli
evaluirana je pomo}u vizualno-analogne skale (VAS) od 1 do 10. Statistika je obuhvatila analizu: One way ANOVA i
Tuckey post-hoc testove. Statisti~ki zna~ajna razlika (p<0,05) na|ena je izme|u ispitanika tretiranih mono-terapijom i
ispitanika tretiranih kombiniranom terapijom. Rezultati ovog istra`ivanja ukazuju da je mono terapija samo kortiko-
steroidima ili samo nonsteroidnim protuupalnim lijekovima manje je efikasna od kombinirane terapije kortikosteroidi-
ma i protuupalnim nesteroidnim lijekovima nakon va|enja impaktiranog donjeg umnjaka.
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